These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 404728)

  • 21. Effects of lead on the induction of hepatic microsomal enzymes by phenobarbital and 3,4-benzpyrene.
    Chow CP; Cornish HH
    Toxicol Appl Pharmacol; 1978 Feb; 43(2):219-28. PubMed ID: 416519
    [No Abstract]   [Full Text] [Related]  

  • 22. Content and activities of microsomal electron transport components during the development of dieldrin-induced hypertrophic hypoactive endoplasmic reticulum.
    Stevens JT; Oberholser KM; Wagner SR; Greene FE
    Toxicol Appl Pharmacol; 1977 Mar; 39(3):411-21. PubMed ID: 404729
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of some effects of dimethyl sulphoxide and dimethyl sulphone on rat liver microsomal enzymes.
    Stock BH; Fouts JR
    Biochem Pharmacol; 1971 Jul; 20(7):1525-36. PubMed ID: 4399524
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug metabolism and drug-induced spectral interactions in human fetal liver microsomes.
    Pelkonen O
    Biochem Pharmacol; 1973 Oct; 22(19):2357-64. PubMed ID: 4147669
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin E, steroids, and liver microsomal hydroxylations.
    Carpenter MP; Howard CN
    Am J Clin Nutr; 1974 Sep; 27(9):966-79. PubMed ID: 4416878
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of linoleic acid hydroperoxide on the hepatic monooxygenase systems of microsomes from untreated, phenobarbital-treated, and 3-methylcholanthrene-treated rats.
    Jeffery E; Kotake A; Azhary RE
    Mol Pharmacol; 1977 May; 13(3):415-25. PubMed ID: 406515
    [No Abstract]   [Full Text] [Related]  

  • 27. Cadmium inhibition of hepatic drug metabolism in the rat.
    Hadley WM; Miya TS; Bousquet WF
    Toxicol Appl Pharmacol; 1974 May; 28(2):284-91. PubMed ID: 4850841
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of banol and paraoxon on the NADPH-cytochrome c reductase activity and cytochrome P-450 content in rats.
    Neskovic NK; Vitorovic SL
    Bull Environ Contam Toxicol; 1977 Oct; 18(4):472-7. PubMed ID: 411532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of dietary iron levels on hepatic drug metabolism in vivo and in vitro in the rat.
    Becking GC
    Biochem Pharmacol; 1972 Jun; 21(11):1585-93. PubMed ID: 4405218
    [No Abstract]   [Full Text] [Related]  

  • 31. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

  • 32. Sex-dependent differences in drug metabolism in the rat. I. Temporal changes in microsomal drug-metabolizing system of the liver during sexual maturation.
    el-Masry S el-D ; Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):267-78. PubMed ID: 4153058
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of phenobarbital and 3,4-benzypyrene on microsomal cytochrome P-450 and NADPH-cytochrome C reductase in regenerating rat liver after partial hepatectomy or chemical injury.
    Katz DI; Stenger RJ; Johnson EA; Datta RK; Rice J
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):180-91. PubMed ID: 413503
    [No Abstract]   [Full Text] [Related]  

  • 34. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of microsomal ethanol oxidation from cytochrome P-450 catalyzed drug metabolism.
    Vatsis KP; Schulman MP
    Adv Exp Med Biol; 1975; 58(00):369-82. PubMed ID: 239541
    [No Abstract]   [Full Text] [Related]  

  • 36. Dimethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)--in vivo and in vitro effects of metabolism by rat liver microsomes--formation of an oxygenated complex.
    Schenkman JB; Wilson BJ; Cinti DL
    Biochem Pharmacol; 1972 Sep; 21(17):2373-83. PubMed ID: 4647071
    [No Abstract]   [Full Text] [Related]  

  • 37. The apparent non-identity of cytochrome c reductase and flavin-dependent azoreductase activities [proceedings].
    Mallett AK; Walker R; King LJ
    Biochem Soc Trans; 1978; 6(6):1302-5. PubMed ID: 744412
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of protein deficiency on the inducibility of the hepatic microsomal drug-metabolizng enzyme system. II. Effect of enzyme kinetics and electron transport system.
    Mgbodile MU; Hayes JR; Campbell TC
    Biochem Pharmacol; 1973 May; 22(10):1125-32. PubMed ID: 4350553
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of cytochrome b5 in cytochrome P-450 enzymes.
    Sasame HA; Thorgeirsson SS; Mitchell JR; Gillette JR
    Adv Exp Med Biol; 1975; 58(00):435-45. PubMed ID: 239544
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.